1 |
Lee, E. K. and J. D. Lee (2004), Solid-phase, N-tenninus-specific, mono- PEGylation of recombinant interferon alpha-2a: Purification, Characterization, and Bioactivity, presented at ISPPP 2004, Aachen, Germany
|
2 |
Lesuisse E., K. Schanck, and C. Colson (1993), Purification and preliminary characterization of the extracellular lipase of Bacillus subtilis 168, an extremely basic pH-tolerant enzyme, Eur. J. Biochem. 216, 155-160
DOI
ScienceOn
|
3 |
Greenwald, R. B., Y. H. Choe, J. McGuire, and C. D. Conover (2003), Effective drug delivery by PEGylated drug conjugates, Advanced Drug Delivery Reviews 55, 217-250
DOI
ScienceOn
|
4 |
Inada, Y., H. Nishimura, and K. Takahashi (1984), Ester synthesis catalyzed by polyethylene glycol-modified lipase in benzene, Biochem. Biophys. Research Comm. 122(2), 845-850
DOI
ScienceOn
|
5 |
Hinds, K. D. and S. W. Kim (2002), Effect of PEG conjugation on insulin properties, Advanced Drug Delivery Reviews 54, 505-530
DOI
ScienceOn
|
6 |
Bailon, P., and W. Verthold (1998), Polyethylene glycol-conjugated pharmaceutical proteins, Pharm. Sci. & Tech. Today 1, 352-356
DOI
ScienceOn
|
7 |
Y ohalem, D. S. and J. W. Lorbeer (1994), Intraspecific metabolic diversity among strains of Burkholderia cepacia isolated from decayed onions, soils, and the clinical environment, Antonie Van Leeuwenhoek 65(2), 111-131
DOI
ScienceOn
|
8 |
Kinstler, O. B., N. E. Grabriel, C. E. Farrar, and R. B. DePrince (1994), N-terminally chemically modified protein compositions and methods, US patent No. 5,824,784
|